Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Highly efficient influenza matrix (M1) proteins

Highly efficient influenza matrix (M1) proteins

US Patent 9951317 · Granted Apr 24, 2018

Estimated economic value: $14,743,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Coronavirus vaccine formulations2025
Coronavirus vaccine formulations2025
Modified RSV F proteins and methods of their use2025
Modified RSV F proteins and methods of their use2025
Modified RSV F proteins and methods of their use2025
Modified RSV F proteins and methods of their use2025
Recombinant bovine immunodeficiency virus-like particles comprising an influenza2025
Vaccine compositions having improved stability and immunogenicity2025
Vaccine compositions having improved stability and immunogenicity2025
Methods and compositions for treating respiratory disease2024
Methods and compositions for treating respiratory disease2024
Methods and compositions for inducing immune responses against Clostridium diffi2024